FDA: PROC MIXED (‼) for ABE [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2021-09-17 15:15 (123 d 11:08 ago) – Posting: # 22581
Views: 873

Hi Mahmoud,

» I think that using proc mixed to fit RTR/TRR/RRT design is not suitable, because in most cases proc mixed produced Estimated G matrix is not positive definite.
»
» So proc GLM recommended by FDA and Emea is more appropriate in the Semi-replicated designs

Please read the entire thread again. The FDA does recommend PROC MIXED for ABE in all guidances.
That’s the problem.

Dif-tor heh smusma 🖖
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

Activity
 Admin contact
21,831 posts in 4,567 threads, 1,553 registered users;
online 5 (0 registered, 5 guests [including 5 identified bots]).
Forum time: Wednesday 01:23 CET (Europe/Vienna)

Research under a paradigm must be a particularly effective way
of inducing paradigm change.    Thomas S. Kuhn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5